<DOC>
	<DOCNO>NCT02395250</DOCNO>
	<brief_summary>The purpose study determine whether autologous T cell bear chimeric antigen receptor specifically recognize glypican-3 ( GPC3 ) safe effective patient relapse refractory hepatocellular carcinoma ( HCC ) .</brief_summary>
	<brief_title>Anti-GPC3 CAR T Treating Patients With Advanced HCC</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Patients HCC must great equal 18 year age less equal age 70 , must life expectancy &gt; 12 week 2 . GPC3 express HCC tissue IHC . 3 . Nondiffuse HCC presence extrahepatic metastasis portal vein vascular invasion . 4 . The liver cirrhosis status ChildPugh A B score equal 7 . 5 . ECOG physical status score equal 01 KPS score high 80 . 6 . Enough venous access apheresis venous sample contraindication blood cell separation 7 . WBC≥2500/ml，PLT≥60×10^9/L，Hb≥9.0g/dL，LY≥0.7×10^9/L，LY % ≥15 % ，Alb≥2.8g/dL， serum lipase amylase＜1.5 ULN，serum creatinine≤2.5mg/dL，ALT AST≤5 ULN，serum total bilirubin≤3.0mg/dL，PT : INR＜1.7 PT beyond normal value less 4 . All laboratory test result stable range , persistent support treatment give . 1 . The transduction efficiency T cell less 30 % amplification T cell via αCD3/CD28 stimulation le 5 time . 2 . Pregnant lactate woman ( safety experimental treatment unborn baby unknown ; The pregnancy status female participant negative serum urine evaluate 48 hrs infusion ) . 3 . Active systemic infection , coagulation disorder major medical illness include cardiovascular , respiratory immune system , myocardial infarction , cardiac arrhythmia , obstructive/restrictive pulmonary disease . 4 . Any form primary immunodeficiency ( Severe Combined Immunodeficiency Disease ) . 5 . Concurrent opportunistic infection ( The experimental treatment evaluate protocol depends intact immune system . Patients decrease immune competence may less responsive experimental treatment susceptible toxicity ) . 6 . History severe immediate hypersensitivity agent include cyclophosphamide , fludarabine , aldesleukin . 7 . Steroid systemically use . 8 . Prior treatment gene therapeutic . 9. past present existence hepatic encephalopathy 10 . The existence unstable active ulcer gastrointestinal bleed 11 . Patients history organ transplantation wait organ transplantation . 12. serum sodium＜125mmol/L 13. baseline serum K＜3.5mmol/L（The patient include serum K≧3.5mmol/L supplementation） 14. patient need anticoagulant therapy ( warfarin heparin ) 15. patient need longterm antiplatelet therapy ( aspirin dose &gt; 300mg/d ; clopidogrel dose &gt; 75mg/d ) 16 . Patients treat radiotherapy within 4 week prior first apheresis . 17 . Patients use fludarabine cladribine chemotherapy within two year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>